Bausch Health Companies BHC Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bausch + Lomb | $1.24B-11.5% | $1.41B+9.7% | $1.28B+0.2% | $1.28B+12.4% | $1.14B-11.2% | |
| Diversified | $185M-27.5% | $255M-1.2% | $258M+17.8% | $219M+6.8% | $205M-10.1% | |
| International | $285M-6.9% | $306M+7.0% | $286M+2.9% | $278M+6.1% | $262M-6.1% | |
| Salix | $639M-7.8% | $693M-3.2% | $716M+14.2% | $627M+15.7% | $542M-14.5% | |
| Solta Medical | $171M+24.8% | $137M-2.1% | $140M+9.4% | $128M+13.3% | $113M-18.1% | |
| Revenue by Product | ||||||
| Other revenues | $24M-14.3% | $28M+16.7% | $24M-7.7% | $26M-18.8% | $32M+3.2% | |
| Price Appreciation Credit | $2M-86.7% | $15M+1,400% | $1M— | $0-100% | $2M-88.9% | |
| Product sales | $2.5B-9.7% | $2.77B+4.2% | $2.66B+6.1% | $2.5B+12.4% | $2.23B-11.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bausch Health Companies break its business down?
- Bausch Health Companies (BHC) reports revenue by business across 5 parts — Bausch + Lomb, Diversified, International, Salix and Solta Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Bausch Health Companies's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bausch Health Companies's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.